UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 8, 2010 MusclePharm Corporation (Exact Name of Registrant as Specified in its Charter) Nevada 000-53166 77-0664193 (State or Other Jurisdiction (Commission File No.) (I.R.S. Employer of Incorporation) Identification Number) 3390 Peoria St., #307, Aurora, CO 80010 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (800) 210-7369 N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 5.02 Departure of Directors and Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) and (c). The Company's Board of Directors has determined to change the titles of its two highest officers. Brad J. Pyatt, who formerly served as the President will now serve as Chief Executive Officer of the Company and Cory Gregory, who formerly served as Executive Vice President will now serve as the President of the Company. There were no changes in the compensation of these two officers as a result of these changes. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MusclePharm Corporation By: /s/ Brad J. Pyatt Name: Brad J. Pyatt Title: President Dated: April 14, 2010